Overview
SNY market data
Price History
SNY price chart · 1M
- O
- 40.05
- H
- 40.05
- L
- 39.25
- C
- 39.58
- Vol
- 172,390.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $40.05
- Previous Close
- $39.52
- Day High
- $40.05
- Day Low
- $39.25
- 52 Week High
- $50.66
- 52 Week Low
- $39.19
- 7 Day Return
- -2.85%
- 30 Day Return
- -8.25%
- 90 Day Return
- -7.48%
- 1 Year Return
- -17.23%
- Daily Notional Volume
- $6.8M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 21.46 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.37 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 4.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 8.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $69.75 – $91.15 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $84.9B · P/B 1.41 · P/S 1.74.
Company News
10 captured
Communiqué de presse : Mise en ligne du document «Q3 2026 aide-mémoire »Globenewswire Inc ·
Press Release : Availability of the aide-mémoire for Q3 2026 resultsGlobenewswire Inc ·
Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - SNS InsiderGlobenewswire Inc ·
Is Regeneron Stock a Bargain Below $800?The Motley Fool ·